comparemela.com

Latest Breaking News On - Derk krieger - Page 1 : comparemela.com

Cognetivity Neurosciences CognICA Platform Successfully Monitors Cognitive Performance in Alzheimer s Patients Receiving Disease-Modifying Therapy

Cognetivity Neurosciences CognICA Platform Successfully Monitors Cognitive Performance in Alzheimer s Patients Receiving Disease-Modifying Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Watch now: Episode 6 – Migraine myths busted

In the sixth and final episode of the Mind Your Migraine series, Dr Derk Krieger, Professor of Neurology and Senior Consultant Neurologist at Mediclinic Parkview Hospital, and his patient Julia Vetter discuss common misconceptions surrounding the condition.

Episode 6 preview: Busting common migraine myths

Caffeine can trigger migraines, right? Wrong (mostly). Although there have been some studies tentatively linking drinking coffee – for example – with causing headaches, in fact this is not usually the case. Surprisingly, caffeine can help reduce inflammation which then brings pain relief. These are the kinds of myths and misconceptions delved into by Dr Derk Krieger, Professor of Neurology and Senior Consultant Neurologist at Mediclinic Parkview Hospital, in the last episode of the Gulf News & Novartis Mind Your Migraine vodcast series. Dr Krieger chats candidly with patient Julia Vetter who describes herself as “not a typical patient for migraine” because she only started suffering episodes in her thirties – busting the idea that migraines always start at a young age.

Mediclinic Parkview uses novel treatment for Alzheimer s dementia

Mediclinic Parkview Hospital has treated the first Alzheimer’s patient outside the US with the new biological therapy Aducanumab, a breakthrough in the treatment of the disease. Alzheimer’s disease affects the memory and causes personality changes in adults, particularly in their late 50s to 60s, with a second spike later beyond 70 years of age. Among dementia-related illnesses, Alzheimer’s accounts for 40-50 per cent of the cases worldwide. In the MENA region alone, the estimated prevalence is currently 6 per cent of all seniors above 60 years of age. Genetic factors play a role, as does lifestyle, levels of education and cognitive exercises in middle and later life.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.